PMC:7299399 / 7465-7946 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T31","span":{"begin":269,"end":281},"obj":"Body_part"},{"id":"T32","span":{"begin":269,"end":273},"obj":"Body_part"},{"id":"T33","span":{"begin":297,"end":303},"obj":"Body_part"},{"id":"T34","span":{"begin":434,"end":443},"obj":"Body_part"},{"id":"T35","span":{"begin":466,"end":475},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma67653"},{"id":"A32","pred":"fma_id","subj":"T32","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma82764"},{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma67180"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma67180"}],"text":"ng already U.S. Food and Drug Administration (FDA)-approved drugs via a process known as drug repurposing.26\nFigure 1 SARS-CoV-2 viral life cycle and potential targets for nanomaterials. SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) receptors on the host cell surface. Transmembrane serine protease 2 (TMPRSS2) facilitates cellular entry through protease activity. Later, viral particles are internalized and enter into endosomes. Due to the low pH of endosomes, vira"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T41","span":{"begin":119,"end":127},"obj":"Disease"},{"id":"T42","span":{"begin":188,"end":196},"obj":"Disease"}],"attributes":[{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ng already U.S. Food and Drug Administration (FDA)-approved drugs via a process known as drug repurposing.26\nFigure 1 SARS-CoV-2 viral life cycle and potential targets for nanomaterials. SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) receptors on the host cell surface. Transmembrane serine protease 2 (TMPRSS2) facilitates cellular entry through protease activity. Later, viral particles are internalized and enter into endosomes. Due to the low pH of endosomes, vira"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T78","span":{"begin":70,"end":71},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T79","span":{"begin":269,"end":273},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T80","span":{"begin":369,"end":377},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"ng already U.S. Food and Drug Administration (FDA)-approved drugs via a process known as drug repurposing.26\nFigure 1 SARS-CoV-2 viral life cycle and potential targets for nanomaterials. SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) receptors on the host cell surface. Transmembrane serine protease 2 (TMPRSS2) facilitates cellular entry through protease activity. Later, viral particles are internalized and enter into endosomes. Due to the low pH of endosomes, vira"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T29","span":{"begin":60,"end":65},"obj":"Chemical"},{"id":"T30","span":{"begin":89,"end":93},"obj":"Chemical"},{"id":"T31","span":{"begin":208,"end":219},"obj":"Chemical"},{"id":"T32","span":{"begin":297,"end":303},"obj":"Chemical"}],"attributes":[{"id":"A29","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A32","pred":"chebi_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/CHEBI_17822"}],"text":"ng already U.S. Food and Drug Administration (FDA)-approved drugs via a process known as drug repurposing.26\nFigure 1 SARS-CoV-2 viral life cycle and potential targets for nanomaterials. SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) receptors on the host cell surface. Transmembrane serine protease 2 (TMPRSS2) facilitates cellular entry through protease activity. Later, viral particles are internalized and enter into endosomes. Due to the low pH of endosomes, vira"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T12","span":{"begin":130,"end":146},"obj":"http://purl.obolibrary.org/obo/GO_0019058"},{"id":"T13","span":{"begin":360,"end":377},"obj":"http://purl.obolibrary.org/obo/GO_0008233"}],"text":"ng already U.S. Food and Drug Administration (FDA)-approved drugs via a process known as drug repurposing.26\nFigure 1 SARS-CoV-2 viral life cycle and potential targets for nanomaterials. SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) receptors on the host cell surface. Transmembrane serine protease 2 (TMPRSS2) facilitates cellular entry through protease activity. Later, viral particles are internalized and enter into endosomes. Due to the low pH of endosomes, vira"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":16,"end":108},"obj":"Sentence"},{"id":"T34","span":{"begin":109,"end":187},"obj":"Sentence"},{"id":"T35","span":{"begin":188,"end":282},"obj":"Sentence"},{"id":"T36","span":{"begin":283,"end":378},"obj":"Sentence"},{"id":"T37","span":{"begin":379,"end":444},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ng already U.S. Food and Drug Administration (FDA)-approved drugs via a process known as drug repurposing.26\nFigure 1 SARS-CoV-2 viral life cycle and potential targets for nanomaterials. SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) receptors on the host cell surface. Transmembrane serine protease 2 (TMPRSS2) facilitates cellular entry through protease activity. Later, viral particles are internalized and enter into endosomes. Due to the low pH of endosomes, vira"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"156","span":{"begin":208,"end":239},"obj":"Gene"},{"id":"157","span":{"begin":241,"end":245},"obj":"Gene"},{"id":"158","span":{"begin":316,"end":323},"obj":"Gene"},{"id":"159","span":{"begin":119,"end":129},"obj":"Species"},{"id":"160","span":{"begin":188,"end":198},"obj":"Species"},{"id":"161","span":{"begin":297,"end":303},"obj":"Chemical"}],"attributes":[{"id":"A156","pred":"tao:has_database_id","subj":"156","obj":"Gene:59272"},{"id":"A157","pred":"tao:has_database_id","subj":"157","obj":"Gene:59272"},{"id":"A158","pred":"tao:has_database_id","subj":"158","obj":"Gene:7113"},{"id":"A159","pred":"tao:has_database_id","subj":"159","obj":"Tax:2697049"},{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"Tax:2697049"},{"id":"A161","pred":"tao:has_database_id","subj":"161","obj":"MESH:D012694"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ng already U.S. Food and Drug Administration (FDA)-approved drugs via a process known as drug repurposing.26\nFigure 1 SARS-CoV-2 viral life cycle and potential targets for nanomaterials. SARS-CoV-2 binds to angiotensin-converting enzyme 2 (ACE2) receptors on the host cell surface. Transmembrane serine protease 2 (TMPRSS2) facilitates cellular entry through protease activity. Later, viral particles are internalized and enter into endosomes. Due to the low pH of endosomes, vira"}